{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:01Z","timestamp":1787027041146,"version":"build-2736575974"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-AG028716"],"award-info":[{"award-number":["P30-AG028716"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL007057"],"award-info":[{"award-number":["T32HL007057"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    Many patients with chronic lymphocytic leukemia (CLL) experience physical dysfunction and low overall fitness. It remains unknown what factors drive CLL physical dysfunction. We assessed physical function and metabolic lipoprotein panels in 106 patients with CLL. In univariate analyses of clinical factors, a longer time since diagnosis was associated with a higher likelihood of dysfunctional aerobic fitness (OR = 3.56, 95% CI: 1.37\u20139.22;\n                    <jats:italic>p<\/jats:italic>\n                    = 0.002) and physical performance (SPPB: OR = 2.03, 95% CI: 1.20\u20133.44;\n                    <jats:italic>p<\/jats:italic>\n                    = 0.004). Having received treatment was associated with a higher likelihood of dysfunctional aerobic fitness (OR = 1.57, 95% CI: 1.02\u20132.40;\n                    <jats:italic>p<\/jats:italic>\n                    = 0.036), SPPB (OR = 1.85, 95% CI: 1.13\u20133.03;\n                    <jats:italic>p<\/jats:italic>\n                    = 0.011) and grip strength (OR = 1.67, 95% CI: 1.10\u20132.55;\n                    <jats:italic>p<\/jats:italic>\n                    =\u00a00.015). We found that several small HDL particle parameters, higher levels of citrate (OR = 2.01, 95% CI: 1.22\u20133.31;\n                    <jats:italic>p<\/jats:italic>\n                    = 0.030), and lower levels of hemoglobin (OR = 0.50, 95% CI: 0.31\u20130.82;\n                    <jats:italic>p<\/jats:italic>\n                    = 0.030) were associated with a higher likelihood of dysfunctional aerobic fitness. Multivariable least absolute shrinkage and selection operator (LASSO)-penalized regression analyses using variable importance measures (VIM) showed that 7.8-nm HDL particles (VIM = 1.000) and total HDL particle levels (VIM = 1.000) were more informative than clinical measures for the odds of dysfunctional aerobic fitness and 6-min walk functional fitness, respectively, while 10.3-nm HDL particles (VIM = 0.383) were more informative for grip strength. Time since diagnosis (VIM = 0.680) and having received treatment (VIM = 0.490) were more informative than lipoprotein measures for the odds of having dysfunctional SPPB. Taken together, we establish significant relationships between clinical and metabolic factors and physical characteristics that might prompt early use of ancillary support services.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2022.933619","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:44:21Z","timestamp":1659487461000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia"],"prefix":"10.3389","volume":"12","author":[{"given":"Andrea","family":"Sitlinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Deal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margery","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik D.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Neely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Neely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Artese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Brice","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Brander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/01720610-201105000-00009","article-title":"Chronic lymphocytic leukemia: the most common leukemia in adults","volume":"24","author":"Washburn","year":"2011","journal-title":"Jaapa"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: a report from the haematological malignancy research network","volume":"105","author":"Smith","year":"2011","journal-title":"Br J Cancer"},{"key":"B3","unstructured":"Leukemia - chronic lymphocytic - CLL: Risk factors2021"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30029-8","article-title":"An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data","volume":"17","year":"2016","journal-title":"Lancet Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.4449","article-title":"Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study","volume":"31","author":"Solomon","year":"2013","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07050.x","article-title":"Early stage chronic lymphocytic leukaemia carrying unmutated IGHV genes is at risk of recurrent infections during watch and wait","volume":"141","author":"Rossi","year":"2008","journal-title":"Br J Haematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2014.05.006","article-title":"Immunomodulation and immune reconstitution in chronic lymphocytic leukemia","volume":"51","author":"Riches","year":"2014","journal-title":"Semin Hematol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41408-019-0237-1","article-title":"Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia","volume":"9","author":"Kumar","year":"2019","journal-title":"Blood Cancer J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382104","article-title":"Chlorambucil in indolent chronic lymphocytic leukemia. French cooperative group on chronic lymphocytic leukemia","volume":"338","author":"Dighiero","year":"1998","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hon.2900060103","article-title":"Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation","volume":"6","author":"Shustik","year":"1988","journal-title":"Hematol Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25292","article-title":"Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia","volume":"116","author":"Shanafelt","year":"2010","journal-title":"Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glv202","article-title":"Physical resilience in older adults: Systematic review and development of an emerging construct","volume":"71","author":"Whitson","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001317","article-title":"Impact of exercise on the immune system and outcomes in hematologic malignancies","volume":"4","author":"Sitlinger","year":"2020","journal-title":"Blood Adv"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2012.04054.x","article-title":"Prevalence of frailty in community-dwelling older persons: a systematic review","volume":"60","author":"Collard","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-746420","article-title":"Frailty and the management of hematologic malignancies","volume":"131","author":"Abel","year":"2018","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1091933","article-title":"Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group","volume":"57","author":"Goede","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt568","article-title":"Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy","volume":"25","author":"Streckmann","year":"2014","journal-title":"Ann Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.0634","article-title":"Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients","volume":"27","author":"Courneya","year":"2009","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1106533","article-title":"Metabolism pathways in chronic lymphocytic leukemia","volume":"57","author":"Rozovski","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-14-0412","article-title":"Aberrant LPL expression, driven by STAT3, mediates free fatty acid metabolism in CLL cells","volume":"13","author":"Rozovski","year":"2015","journal-title":"Mol Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/cells10051165","article-title":"Physiological fitness and the pathophysiology of chronic lymphocytic leukemia (CLL)","volume":"10","author":"Sitlinger","year":"2021","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/aje\/kwj248","article-title":"Validation of a new brief physical activity survey among men and women aged 60-69 years","volume":"164","author":"Taylor-Piliae","year":"2006","journal-title":"Am J Epidemiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3810\/psm.2011.05.1904","article-title":"The 6-minute walk test as a predictor of objectively measured aerobic fitness in healthy working-aged adults","volume":"39","author":"Burr","year":"2011","journal-title":"Phys Sportsmed"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/00005768-199912000-00018","article-title":"Aerobic fitness in a population of independently living men and women aged 55-86 years","volume":"31","author":"Paterson","year":"1999","journal-title":"Med Sci Sports Exerc"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/49.2.M85","article-title":"A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission","volume":"49","author":"Guralnik","year":"1994","journal-title":"J Gerontol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2014.07.015","article-title":"NMR measurement of LDL particle number using the vantera clinical analyzer","volume":"47","author":"Matyus","year":"2014","journal-title":"Clin Biochem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2014.232918","article-title":"GlycA: A composite nuclear magnetic resonance biomarker of systemic inflammation","volume":"61","author":"Otvos","year":"2015","journal-title":"Clin Chem"},{"key":"B29","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/joim.12953","article-title":"GlycA, a novel pro-inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta-analysis","volume":"286","author":"Gruppen","year":"2019","journal-title":"J\u00a0Internal Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.3390\/jcm9092915","article-title":"Characterization of LP-z lipoprotein particles and quantification in subjects with liver disease using a newly developed NMR-based assay","volume":"9","author":"Bedi","year":"2020","journal-title":"J Clin Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1089\/met.2014.0050","article-title":"Lipoprotein insulin resistance index: a lipoprotein particle\u2013derived measure of insulin resistance","volume":"12","author":"Shalaurova","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/37.3.377","article-title":"Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy","volume":"37","author":"Otvos","year":"1991","journal-title":"Clin Chem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2018.02.001","article-title":"A novel NMR-based assay to measure circulating concentrations of branched-chain amino acids: Elevation in subjects with type 2 diabetes mellitus and association with carotid intima media thickness","volume":"54","author":"Wolak-Dinsmore","year":"2018","journal-title":"Clin Biochem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2017.06.003","article-title":"NMR quantification of trimethylamine-n-oxide in human serum and plasma in the clinical laboratory setting","volume":"50","author":"Garcia","year":"2017","journal-title":"Clin Biochem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3390\/jcm8111813","article-title":"High betaine, a trimethylamine n-oxide related metabolite, is prospectively associated with low future risk of type 2 diabetes mellitus in the PREVEND study","volume":"8","author":"Garcia","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.10.018","article-title":"The effects of exercise on the lipoprotein subclass profile: A meta-analysis of 10 interventions","volume":"243","author":"Sarzynski","year":"2015","journal-title":"Atherosclerosis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802959","article-title":"Aerobic exercise, lipids and lipoproteins in overweight and obese adults: a meta-analysis of randomized controlled trials","volume":"29","author":"Kelley","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1995.268.2.E229","article-title":"Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not adipose tissue","volume":"268","author":"Seip","year":"1995","journal-title":"Am J Physiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3390\/biom10121699","article-title":"The regulation of fat metabolism during aerobic exercise","volume":"10","author":"Muscella","year":"2020","journal-title":"Biomolecules"},{"key":"B40","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3109\/10428194.2015.1088651","article-title":"A link between hypercholesterolemia and chronic lymphocytic leukemia","volume":"57","author":"Chow","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw226","article-title":"The association of dyslipidemia with chronic lymphocytic leukemia: A population-based study","volume":"109","author":"Mozessohn","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-382171-3.10007-5","article-title":"Chapter 7 - apolipoprotein a-I mutations","volume-title":"The HDL handbook","author":"Matsunaga","year":"2010"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16859","article-title":"High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population-based study","volume":"190","author":"Larsson","year":"2020","journal-title":"Br J Haematol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ebiom.2016.11.033","article-title":"Low density lipoproteins amplify cytokine-signaling in chronic lymphocytic leukemia cells","volume":"15","author":"McCaw","year":"2017","journal-title":"EBioMedicine"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01432-7","article-title":"Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications","volume":"39","author":"Wei","year":"2020","journal-title":"Oncogene"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.602476","article-title":"Extracellular citrate fuels cancer cell metabolism and growth","volume":"8","author":"Haferkamp","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.07.032","article-title":"Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity","volume":"34","author":"Mansouri","year":"2010","journal-title":"Leuk Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15427","article-title":"LPL protein in chronic lymphocytic leukaemia have different origins in mutated and unmutated patients. Advances for a new prognostic marker in CLL","volume":"182","author":"Prieto","year":"2018","journal-title":"Br J Haematol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ebiom.2016.12.001","article-title":"Lipids and their effects in chronic lymphocytic leukemia","volume":"15","author":"Friedman","year":"2017","journal-title":"EBioMedicine"},{"key":"B50","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.molmed.2013.02.006","article-title":"The role of triglyceride lipases in cancer associated cachexia","volume":"19","author":"Das","year":"2013","journal-title":"Trends Mol Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF00311770","article-title":"Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate","volume":"26","author":"Nomura","year":"1996","journal-title":"Surg Today"},{"key":"B52","doi-asserted-by":"publisher","first-page":"23137","DOI":"10.1038\/s41598-021-02352-6","article-title":"A pilot study of high-intensity interval training in older adults with treatment na\u00efve chronic lymphocytic leukemia","volume":"11","author":"MacDonald","year":"2021","journal-title":"Sci Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3993","article-title":"The chronic lymphocytic leukemia comorbidity index (CLL-CI): A three-factor comorbidity model","volume":"27","author":"Gordon","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16879","article-title":"Medical comorbidities in patients with chronic lymphocytic leukaemia treated with idelalisib: analysis of two large randomised clinical trials","volume":"192","author":"Gordon","year":"2021","journal-title":"Br J Haematol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.933619\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:44:26Z","timestamp":1659487466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.933619\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":54,"alternative-id":["10.3389\/fonc.2022.933619"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.933619","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"article-number":"933619"}}